Biotech Growth Share Discussion Threads

[affemoose] 11/6/2015 11:50

Ooops, meant the post the below in case you do not know already. Sorry about above rant!!

Geoffrey Hsu of OrbiMed Capital LLC, the Portfolio Manager of The Biotech Growth Trust PLC, will be presenting to investors and shareholders in London on Wednesday, 8 July 2015. BIOG has performed exceptionally well over a sustained period, significantly outperforming both the FTSE All-Share benchmark and the NASDAQ Biotechnology Index over 1, 3 and 5 years.
OrbiMed is the world's largest specialist healthcare fund manager with over $15bn invested worldwide. Geoffrey Hsu will provide an update on the biotech sector and the factors determining future growth.

The presentation will start soon after 12.15pm, immediately after the conclusion of the ordinary business of the AGM, which commences at 12 noon.
More information on The Biotech Growth Trust PLC can be found at www.biotechgt.com. Details are as follows:
BIOG AGM and Investor Presentation:
Date: Wednesday 8th July
Time: 12 noon – AGM
12:15 – Investor Presentation
13:30 – Buffet Lunch
Venue: Barber Surgeons' Hall, Monkwell Square, London EC2Y 5BD
Please RSVP to [e-mail] if you are able to join us, as places are limited.

[philo124] 02/6/2015 14:24

Creeping up.

[affemoose] 29/4/2015 14:38

probably, but i find it best to have money to grip with!!

be back when I have some - all sitting in lawyers, Estate Agents and HMRC's pockets at the moment.

[jl9] 29/4/2015 14:17

Thanks. I agree this is an exciting area for growth. But you can only capture it with certainty by gritting your teeth and holding on through the ups and downs.

[affemoose] 29/4/2015 13:49

2 fold - yes to personalised, but also targeted as in targeting a specific disease.

Most cancers are, I believe, not 1 cancer but different ones targeting the same body areas. so for instance there is more than 1 lung cancer, prostate cancer etc.

Up to now drugs are just for 'prostate' - but they are moving towards hitting each cancer in its own right, which will then lead to personalised longer term.

Anyway - that's my ramblings.

[jl9] 29/4/2015 12:38

AffeMoose - by 'targeted drugs' do you mean personalised medicine?

[affemoose] 29/4/2015 10:14

Well - I got out of here a few short weeks back as I needed the cash for a house.

But I do like BIOG and have kept a close eye on things since and what a rollercoaster ride you have all had!!

I sold at something like 798. Since then i dropped, roared above to mid 800's, slumped back to mid 700's etc etc

I have gone from patting myself on the back to kicking myself to being glad I sold when i did.

I have absolutely no idea whatsoever where the next few months will take this - my guess is targeted at 720, if it breaks through this then 675.

My uninformed guess is that this share will move, in a very volatile way, sideways for a while. Spiking and crashing it's way across the chart for a while.

BUT - longer term I cannot see this sector going anywhere except upwards. We are just at the start of this journey into Targeted drugs.

SO - selfishly - I hope for the 600's to be revisited so when i do have some cash, I can get in at a decent price again. But GLA in your holdings.

[philo124] 28/4/2015 11:02

Have a look at the forward p/e ratios of the constituents of the DJIA- they are not stretched imo. In a deflationary environment what are the sectors that have growth and pricing power? I can only think of 2.

[mad foetus] 28/4/2015 10:53

This is on my buy list, I just cannot bring myself to buy at this price. I cannot believe that we'll get through the summer without the market having a wobble, and when it does, there are half a dozen trusts on a discount that will become bargains. Of course, it may not happen and I may miss out.

[philo124] 28/4/2015 10:49

They have a mandate to buy back when discount is greater than 8%.
Whether it's 760p or 660p, the price will be 1200p+ in 5 years time.

[redhill9] 28/4/2015 10:45

Thanks. So it seems we can expect a significant drop in next NAV.

[redhill9] 28/4/2015 09:41

The sector or specifically BIOG? Recovered some now - they were down over 40p / 5% at the open.

[robow] 28/4/2015 09:14

biotech shares were weak overnight on Wall St

[redhill9] 28/4/2015 08:34

Large fall in share price this morning with a few sells. NAV at 867p suggests a discount now of around 13% compared to the more usual c.7%. Anyone any ideas on the reason for the drop in sp? I know BIOG share price can be a bit volatile but usually that's caused by similar movement in NAV.

[philo124] 08/4/2015 21:11

I have seen a presentation fwiw and believe that this sector is one not to be out of long term. £1000 invested in IBB- Biotech Index in 1993 would be now worth £1,483,000. Makes you think about holding long term if you have young children.

[bigwilly1986] 08/4/2015 17:39

It has the potential to be a bubble, but I am reassured by a) the frequent mini-crashes and b) the discount!

[philo124] 08/4/2015 15:33

I sold some at £5.50 and £6.40 thinking the same; I think we are both wrong but I guess it's about risk management.

[wingrove4] 08/4/2015 13:42

Sold out of my holding today for a healthy proper profit. Worried this could be like a dotcom bubble. Good luck to all those that hold

[strollingmolby] 06/4/2015 08:36

Woodford referring to certain Nasdaq stocks at punchy valuations, not the UK private stocks he'll be buying...

[wingrove4] 06/4/2015 07:23

Article in Moneyweek saying biotech stocks could be in bubble territory any thoughts?

[stewpot3] 01/4/2015 16:42

Never a dull moment with this share.

[robotface] 26/3/2015 14:00

Looks like a reversal underway